DENTSPLY SIRONA (NASDAQ:XRAY) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a hold rating to a buy rating in a research note issued to investors on Friday morning.

A number of other equities research analysts have also weighed in on XRAY. Mizuho assumed coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, December 4th. They set a “neutral” rating and a $21.00 target price for the company. Needham & Company LLC upped their price objective on DENTSPLY SIRONA from $23.00 to $25.00 and gave the company a “buy” rating in a research report on Thursday, January 30th. Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Barrington Research reduced their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Finally, Morgan Stanley lowered their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 17th. Nine analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $26.33.

DENTSPLY SIRONA Stock Down 2.3 %

NASDAQ XRAY opened at $18.76 on Friday. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $34.91. The stock has a 50-day moving average of $19.13 and a 200 day moving average of $22.29. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.49 EPS. As a group, analysts forecast that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.41%. The ex-dividend date of this dividend was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio is currently -30.92%.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. State of Alaska Department of Revenue increased its holdings in DENTSPLY SIRONA by 2.4% in the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock valued at $637,000 after acquiring an additional 560 shares during the last quarter. UMB Bank n.a. increased its holdings in shares of DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 564 shares during the last quarter. MML Investors Services LLC increased its holdings in shares of DENTSPLY SIRONA by 2.1% in the third quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock worth $803,000 after purchasing an additional 620 shares during the last quarter. Allworth Financial LP lifted its position in shares of DENTSPLY SIRONA by 40.2% in the third quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock worth $59,000 after buying an additional 625 shares in the last quarter. Finally, Blue Trust Inc. boosted its stake in DENTSPLY SIRONA by 10.9% during the fourth quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock valued at $137,000 after buying an additional 707 shares during the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.